Abstract:Abstract: The tumor suppressor protein p53, a transcription factor playing a key role in cancer prevention, interacts with DNA as its primary means of determining cell fate in the event of DNA damage. When it becomes mutated, it opens damaged cells to the possibility of reproducing unchecked, which can lead to formation of cancerous tumors. Despite its critical role, therapies at the molecular level to restore p53 native function remain elusive, due to its complex nature. Nevertheless, considerable information has been amassed, and new means of investigating the problem have become available. Objectives: We consider structural, biophysical, and bioinformatic insights and their implications for the role of direct and indirect readout and how they contribute to binding site recognition, particularly those of low consensus. We then pivot to consider advances in computational approaches to drug discovery. Materials and methods: We have conducted a review of recent literature pertinent to the p53 protein. Results: Considerable literature corroborates the idea that p53 is a complex allosteric protein that discriminates its binding sites not only via consensus sequence through direct H-bond contacts, but also a complex combination of factors involving the flexibility of the binding site. New computational methods have emerged capable of capturing such information, which can then be utilized as input to machine learning algorithms towards the goal of more intelligent and efficient de novo allosteric drug design. Conclusions: Recent improvements in machine learning coupled with graph theory and sector analysis hold promise for advances to more intelligently design allosteric effectors that may be able to restore native p53-DNA binding activity to mutant proteins. Clinical relevance: The ideas brought to light by this review constitute a significant advance that can be applied to ongoing biophysical studies of drugs for p53, paving the way for the continued development of new methodologies for allosteric drugs. Our discoveries hold promise to provide molecular therapeutics which restore p53 native activity, thereby offering new insights for cancer therapies. Graphical abstract: Structural representation of the p53 DBD (PDBID 1TUP). DNA consensus sequence is shown in gray, and the protein is shown in blue. Red beads indicate hotspot residue mutations, green beads represent DNA interacting residues, and yellow beads represent both.

The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.

Interaction Between P53 and TRF1、TRF2 and Analysis of Binding Domain of P53 in vitro

Comparison of the Protein-Protein Interfaces in the P53-Dna Crystal Structures: Towards Elucidation of the Biological Interface.

Molecular dynamics-based computational investigations on the influence of tumor suppressor p53 binding protein against other proteins/peptides

p53: The Multifaceted Roles of Covalent Modifications in Cancer

Conformational Stability and Dynamics of the Cancer‐associated Isoform Δ133p53β Are Modulated by P53 Peptides and P53‐specific DNA

[The Molecular Interaction Between P53 and Telomeric Repeat Binding Protein 1 in Vitro].

Mechanisms of P53 Core Tetramer Stability Mediated by Multi-Interface Interactions: A Molecular Dynamics Study

Full-atomistic Molecular Dynamics Analysis of p53 Active Tetramer

In Vitro Binding of P53 and Telomeric Repeat Factor 2

Structural modulation of p53TAD1-TAZ2 complex upon mutations and post-translational modification

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

p53 modifications: exquisite decorations of the powerful guardian

Coordination of the Nuclear and Cytoplasmic Activities of P53 in Response to DNA Damage

Lysine120 interactions with p53 response elements can allosterically direct p53 organization

Structure and Stability Insights into Tumour Suppressor p53 Evolutionary Related Proteins

Quantum Mechanical Studies of Residue-Specific Hydrophobic Interactions in P53-Mdm2 Binding.

Navigating the complexity of p53-DNA binding: implications for cancer therapy

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2

The P53 Protein Is A Novel Substrate Of Ribosomal S6 Kinase 2 And A Critical Intermediary For Ribosomal S6 Kinase 2 And Histone H3 Interaction

Symphony of the DNA flexibility and sequence environment orchestrates p53 binding to its responsive elements